Annexon, Inc.
Annexon, Inc. (ANNX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ANNX · as of Jun 8, 2026
Activity summary
Buy transactions
16
P-Purchase only
Sell transactions
13
12 Months
Buy/Sell ratio
1.23
Buy/Sell (by trades)
Overall sentiment
Annexon, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ANNX insider buying and selling by quarter
ANNX insider selling · ANNX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · ANNX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ANNX executive sell shares · ANNX board member insider trading · ANNX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 28, 2026 | Satter Muneer A Director | Purchase | 613,497 | $3.32M⚡ | Form 4 |
| May 11, 2026 | Carson William H. Director | Purchase | 8,000 | $46K | Form 4 |
| Apr 10, 2026 | Carson William H. Director | Purchase | 8,000 | $50K | Form 4 |
| Mar 10, 2026 | Carson William H. Director | Purchase | 8,000 | $45K | Form 4 |
| Mar 2, 2026 | Dananberg Jamie CHIEF MEDICAL OFFICER | Sale | 5,820 | $32K | Form 4 |
| Mar 2, 2026 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | 4,339 | $24K | Form 4 |
| Mar 2, 2026 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | 5,566 | $30K | Form 4 |
| Mar 2, 2026 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sale | 5,894 | $32K | Form 4 |
| Mar 2, 2026 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | 5,565 | $30K | Form 4 |
| Feb 19, 2026 | Dananberg Jamie CHIEF MEDICAL OFFICER | Award | 56,250 | — | Form 4 |
| Feb 19, 2026 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Award | 62,500 | — | Form 4 |
| Feb 19, 2026 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Award | 62,500 | — | Form 4 |
| Feb 19, 2026 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Award | 62,500 | — | Form 4 |
| Feb 19, 2026 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Award | 62,500 | — | Form 4 |
| Feb 18, 2026 | Dananberg Jamie CHIEF MEDICAL OFFICER | Sale | 5,290 | $27K | Form 4 |
| Feb 18, 2026 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | 7,851 | $40K | Form 4 |
| Feb 18, 2026 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sale | 5,290 | $27K | Form 4 |
| Feb 18, 2026 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | 7,857 | $40K | Form 4 |
| Feb 18, 2026 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | 6,225 | $32K | Form 4 |
| Dec 30, 2025 | Carson William H. Director | Purchase | 4,115 | $21K | Form 4 |
| Dec 1, 2025 | Choi Jung Director | Purchase | 33,000 | $138K | Form 4 |
| Dec 1, 2025 | Carson William H. Director | Purchase | 4,115 | $18K | Form 4 |
| Nov 21, 2025 | Satter Muneer A Director | Purchase | 422,613 | $1.81M⚡ | Form 4 |
| Nov 20, 2025 | Satter Muneer A Director | Purchase | 400,000 | $1.79M⚡ | Form 4 |
| Nov 19, 2025 | Satter Muneer A Director | Purchase | 500,000 | $1.97M⚡ | Form 4 |
Dananberg Jamie
CHIEF MEDICAL OFFICER
Date
Mar 2
Shares
5,820
Price
$5.43
Value
$32K
Overdorf Michael
EVP & CHIEF BUSINESS OFFICER
Date
Mar 2
Shares
4,339
Price
$5.42
Value
$24K
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
Date
Mar 2
Shares
5,566
Price
$5.42
Value
$30K
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
Date
Mar 2
Shares
5,894
Price
$5.43
Value
$32K
Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER
Date
Mar 2
Shares
5,565
Price
$5.42
Value
$30K
Overdorf Michael
EVP & CHIEF BUSINESS OFFICER
Date
Feb 19
Shares
62,500
Price
—
Value
—
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
Date
Feb 19
Shares
62,500
Price
—
Value
—
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
Date
Feb 19
Shares
62,500
Price
—
Value
—
Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER
Date
Feb 19
Shares
62,500
Price
—
Value
—
Dananberg Jamie
CHIEF MEDICAL OFFICER
Date
Feb 18
Shares
5,290
Price
$5.10
Value
$27K
Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER
Date
Feb 18
Shares
7,851
Price
$5.11
Value
$40K
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
Date
Feb 18
Shares
5,290
Price
$5.10
Value
$27K
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
Date
Feb 18
Shares
7,857
Price
$5.11
Value
$40K
Overdorf Michael
EVP & CHIEF BUSINESS OFFICER
Date
Feb 18
Shares
6,225
Price
$5.10
Value
$32K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ANNX insider trading
ANNX insider trades
Annexon, Inc. (ANNX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Carson William H. (Director), Satter Muneer A (Director), Overdorf Michael (EVP & CHIEF BUSINESS OFFICER). Over the past 12 months, 5 insiders have filed transactions with the SEC. ANNX insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Annexon, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ANNX insider trading · 5 questionsThe insiders of Annexon, Inc. (ANNX) include executives and directors such as Carson William H. (Director), Satter Muneer A (Director), Overdorf Michael (EVP & CHIEF BUSINESS OFFICER), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026